Cohbar Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | Cohbar Inc.

Cohbar Inc. | Ownership

Companies that own Cohbar Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

The Vanguard Group, Inc.

1,267,086

2.98%

20,583

07/31/2018

BlackRock Fund Advisors

995,729

2.35%

995,729

06/30/2018

SSgA Funds Management, Inc.

304,143

0.72%

304,143

06/30/2018

Optimum Investment Advisors LLC

277,290

0.65%

5,950

0.4%

03/31/2018

Northern Trust Investments, Inc.

249,809

0.59%

249,809

06/30/2018

Geode Capital Management LLC

249,078

0.59%

249,078

06/30/2018

JPMorgan Securities LLC (Investment Management)

77,149

0.18%

77,149

06/30/2018

BlackRock Investment Management LLC

73,834

0.17%

73,834

06/30/2018

Goldman Sachs & Co. LLC (Private Banking)

57,933

0.14%

25,928

06/30/2018

The Bank of New York Mellon Corp. (Investment Management)

53,673

0.13%

53,673

06/30/2018

About Cohbar

View Profile

Address	1455 Adams Drive Pasadena California 94025 United States
Employees	-
Website	http://www.cohbar.com
Updated	07/08/2019
CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.